Invention Grant
- Patent Title: Tetrazole compounds as calcium channel blockers
-
Application No.: US14802982Application Date: 2015-07-17
-
Publication No.: US09750719B2Publication Date: 2017-09-05
- Inventor: Paul Beswick , Robert James Gleave , Shuji Hachisu , Sadie Vile , Nicolas Bertheleme , Simon E. Ward
- Applicant: CONVERGENCE PHARMACEUTICALS LIMITED
- Applicant Address: GB London
- Assignee: CONVERGENCE PHARMACEUTICALS LIMITED
- Current Assignee: CONVERGENCE PHARMACEUTICALS LIMITED
- Current Assignee Address: GB London
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/41
- IPC: A61K31/41 ; A61K31/435 ; A61K31/4439 ; A61K31/5386 ; C07D257/04 ; C07D257/06 ; C07D401/14 ; C07D403/06 ; C07D413/06 ; C07D417/06 ; C07D471/10 ; C07D487/14 ; C07D487/08 ; C07D491/08 ; C07D513/04 ; C07D471/04 ; C07D487/04 ; A61K31/496 ; A61K31/4985 ; A61K31/5377 ; A61K31/541 ; A61K31/551
Abstract:
The present invention relates to novel tetrazole compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial. Formula (I) wherein A is: (II) or (III) wherein A is
Public/Granted literature
- US20160015687A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Public/Granted day:2016-01-21
Information query
